HIV/AIDS: US Withdrawal from WHO

Viscount Stansgate Excerpts

Thursday 20th March 2025 Lords Chamber

[Baroness Chapman of Darlington (Lab)]

Absolutely not. Why would we do that? It is our ambition to regain the 0.7% spend on official development assistance. We have been very clear about that. Why would we repeal that legislation? I find it very difficult that we are spending so much money on housing asylum seekers and migrants in the UK out of our ODA budget. I do not think that is what we should be doing. The previous Government completely lost control of the borders of this country and we have inherited this situation. The Home Office is working hard to get the numbers down and to reduce the spend so that money can be spent where it is needed most. We did make the decision—and it was a difficult one for this Government—to prioritise spending on defence. I do not think I need to explain to noble Lords why we did that. It is a decision I support, and I will be working incredibly hard, with allies and partners, to make sure that the money that we do have is spent wisely, and that we get the best value for money for British taxpayers and the most impact that we can for our partners overseas.

[Viscount Stansgate (Lab)]

My Lords, last week, I co-hosted on behalf of the parliamentary Science and Technology Committee a meeting of STOPAIDS in this House. We heard from people from Africa whose ability to access drugs had, in one case, enabled a woman to live to become a grandmother. We heard about the devastating effect, mentioned by the noble Lord, Lord Fowler, of the cuts in USAID, for which we are not responsible. I hope my noble friend the Minister will understand that, to the extent that Britain can continue to play its part in trying to reach the 2030 target, it must use the resources, scarce though they are, to enable this work to continue. We cannot allow the world to go backwards. This needs to be tackled now.

[Baroness Chapman of Darlington (Lab)]

I completely agree. There are encouraging things happening around some of the medical devices and the drugs that can be used now to provide protection against HIV, including devices for which women are in control of their use, because we are seeing an increase in prevalence among women and young girls. There are encouraging things happening, but it would be incredible to stand here and say that the situation that we now find ourselves in is not far more challenging than it has been more recently.